Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

CADL

CADL News

Newswire

08:36

Cadence Design Systems Q4 rev. down 2% YoY to $309 mln.

17:27

Candel Therapeutics shares surge 12.33% after-hours after announcing virtual R&D event on December 5, 2025.

15:01

Candel Therapeutics: Citigroup maintains Buy, PT down to $24 from $25.

11:49

Candel Pauses Development of CAN-2409 for Prostate Cancer Type, Focuses on Pancreatic Adenocarcinoma.

16:35

Candel Therapeutics Highlights Positive Clinical Progress Across Cancer Immunotherapy Pipeline in Q3 2025

View More

About CADL

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More